C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
07/2004
07/28/2004	CN1515316A Combined therapeutic method for osteoporosis
07/28/2004	CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor
07/28/2004	CN1515258A Combined therapeutic method for osteoporosis
07/28/2004	CN1515254A Combined therapeutic method for osteoporosis
07/28/2004	CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives
07/28/2004	CN1159301C Intermediates for preparation of triazoline herbicide and its preparing process
07/28/2004	CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives
07/27/2004	US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents
07/27/2004	US6767909 Cardiovascular disorders; vasoconstriction
07/27/2004	CA2331261C 2"-deoxy hygromycin derivatives
07/22/2004	WO2004060869A2 Methods and compositions for catalytic dna exchange in a sequence manner
07/22/2004	WO2004060868A2 Harvesting yew biomass for extraction of taxanes and other natural products
07/22/2004	US20040142931 inhibit the tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4
07/22/2004	US20040141906 Novel graphite nanocatalysts
07/22/2004	CA2512095A1 Harvesting yew biomass for extraction of taxanes and other natural products
07/21/2004	EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
07/21/2004	EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite
07/21/2004	EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
07/21/2004	EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
07/21/2004	EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
07/21/2004	CN1514828A Pyrazole derivatives for treating HIV
07/21/2004	CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
07/20/2004	US6765008 Pyrrolopyrimidines as CRF antagonists
07/15/2004	WO2004058757A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
07/15/2004	WO2004058756A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
07/15/2004	WO2004058703A2 Methods of identifying longevity modulators and therapeutic methods of use thereof
07/15/2004	WO2004058700A2 Mitotic kinesin inhibitors
07/15/2004	WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
07/15/2004	US20040138288 Anticancer compounds
07/15/2004	US20040138267 Antitumor agents
07/15/2004	US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers
07/15/2004	US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004	CA2508956A1 Mitotic kinesin inhibitors
07/14/2004	EP1436296A2 Process for the direct preparation of pyrrolo 3,4-c]pyrroles
07/14/2004	EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004	EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals
07/14/2004	CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
07/14/2004	CN1511833A Process for preparing isoxazolyl alkyl diketone compound
07/14/2004	CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
07/14/2004	CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
07/13/2004	US6762308 Method for the preparation of citalopram
07/13/2004	US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
07/13/2004	CA2386775C Drugs for the treatment of malignant tumours
07/08/2004	WO2004056324A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
07/08/2004	WO2003097593A3 Protease inhibitors
07/08/2004	US20040132808 precipitating the citalopram base in crystalline form, and transforming the base into a pharmaceutically acceptable citalopram salt; useful for removing intermediates which are structurally closely related to citalopram
07/08/2004	US20040132794 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
07/08/2004	US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004	US20040132729 Inhibitors of p38
07/07/2004	EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
07/07/2004	EP1434588A2 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
07/07/2004	CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor
07/07/2004	CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors
07/07/2004	CN1156449C Process for preparing N-(amino-4,6-dihalopyrimidine) formamide
07/01/2004	WO2004055026A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
07/01/2004	WO2004054969A2 Sacromastigophoric therapeutic agent delivery system
07/01/2004	WO2004054514A2 C-6 modified indazolylpyrrolotriazines
07/01/2004	WO2004039774A3 Mitotic kinesin inhibitors
07/01/2004	WO2004029025A3 Methods and compositions for the treatment of autoimmune disorders using clofarabine
07/01/2004	US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors
06/2004
06/30/2004	EP0958289B1 Amino acid ester containing azole antifungals
06/30/2004	CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene
06/30/2004	CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene
06/30/2004	CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
06/30/2004	CN1155596C New phenylpiperazines
06/30/2004	CN1155584C Process for preparation of 1,4,7,10-tetraazacyclododecane
06/30/2004	CN1155579C Synthesis of histamine dihydrochloride
06/29/2004	US6756503 Reacting propene with hydrogen peroxide in methanol to give mixture including propylene oxide, methanol, water and hydrogen peroxide, separating methanol, water and hydrogen peroxide, separating water from methanol and methyl formate
06/29/2004	US6756377 Compounds and their use
06/29/2004	CA2205384C Dihydropyrimidines and uses thereof
06/24/2004	WO2004052850A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
06/24/2004	WO2004011425A3 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
06/24/2004	WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
06/24/2004	WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/24/2004	US20040122055 C10 carbonate taxane compositions
06/24/2004	DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium
06/24/2004	CA2508619A1 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
06/23/2004	CN1506350A Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll
06/23/2004	CN1154643C Improved phlegmatization of cyclic ketone peroxides
06/23/2004	CN1154642C Pyranone compounds useful to treat retroviral infections
06/23/2004	CN1154637C Method for producing substituted pyrazoles
06/23/2004	CN1154636C Process for preparnig intermediate in preparation of substd. peperidines
06/22/2004	US6753331 Heterocyclic derivatives which inhibit factor Xa
06/17/2004	US20040116697 Novel compounds
06/16/2004	EP1427711A1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
06/16/2004	EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
06/16/2004	EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
06/16/2004	EP1268469B1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
06/16/2004	EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
06/16/2004	EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
06/16/2004	CN1505631A Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands
06/16/2004	CN1505614A Process for making amlodipine maleate
06/16/2004	CN1153773C Salts of optically active sulfoxide derivative
06/16/2004	CN1153764C Substituted benzylaminopiperidine compounds
06/15/2004	US6750245 C7 carbamate substituted taxanes
06/15/2004	US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis
06/15/2004	CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump
06/15/2004	CA2087880C N-5-protected 2,5-diamino-4,6-dichloropyrimidines and process for their production
06/10/2004	WO2004048328A2 N-arylsulfonyl-3-aminoalkoxyindoles
06/10/2004	US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct

1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 105